Creatine, testosterone, and DHT: what newer research says about the hormone rumor
One small rugby study raised concern about DHT, but later trials found no consistent testosterone, DHT, or hair-follicle effect from creatine.

Creatine's performance evidence should not be confused with a testosterone effect. A single DHT signal has not been consistently replicated.
A performance supplement acquired a hormone story
Creatine monohydrate is widely used to support high-intensity exercise and training adaptations. It is sometimes marketed—or criticized—as if it works by raising testosterone or dihydrotestosterone. Those hormone claims are separate from the better-known performance question and require their own evidence.
A supplement can improve repeated high-intensity work without changing reproductive hormones. Mechanism matters because consumers may buy creatine expecting a testosterone boost or avoid it because of a DHT and hair-loss rumor. Neither decision should rest on a claim the relevant studies did not consistently support.

The 2009 rugby study started the DHT concern
A double-blind crossover study in 20 college-aged rugby players used a seven-day creatine loading phase followed by two weeks of maintenance. Testosterone did not change, but DHT and the DHT-to-testosterone ratio increased from baseline during creatine use. The paper called for further investigation.
The study was small, short, and did not measure hair loss. Its finding is a legitimate signal, not proof of a long-term clinical effect. A baseline change within a compact experiment needs replication against placebo with direct outcomes before it can establish that creatine causes androgen-related symptoms.
Other controlled work did not show a testosterone effect
A 2001 double-blind crossover study examined hormone responses to heavy resistance exercise before and after short-term creatine or placebo. Creatine did not significantly alter the testosterone response. This result fits the broader distinction between creatine's energy-system role and a supposed testosterone-boosting mechanism.
Study designs and hormone sampling times differ, so no single trial settles every question. Still, repeated absence of a testosterone effect means product pages should not imply that creatine's strength or lean-mass benefits demonstrate higher testosterone. Performance and hormone outcomes must be reported separately.
A 2025 trial directly examined the rumor
A 12-week randomized controlled trial published in 2025 assigned resistance-trained men to five grams of creatine daily or placebo. Investigators measured total testosterone, free testosterone, DHT, the DHT-to-testosterone ratio, and direct hair-follicle outcomes. Thirty-eight participants completed the study.
There were no significant group-by-time differences in the hormones or hair measures. The trial was still modest in size and duration, so it cannot prove zero risk for every person over years. It does provide more direct evidence than extrapolating hair loss from the older short-term DHT signal.

Use creatine for the claim it can support
When comparing creatine products, separate evidence for exercise performance from claims about testosterone, sexual health, or hair. Look for creatine monohydrate amount, serving instructions, and quality information. A multi-ingredient pre-workout introduces other compounds and cannot be evaluated as if it were creatine alone.
People with medical conditions, medication use, or specific laboratory concerns should discuss supplementation with a qualified professional. This guide does not prescribe creatine. The current evidence does not support selling it as a testosterone booster, and the isolated DHT finding has not been confirmed by a newer trial that measured both hormones and hair directly.
Why direct outcomes matter
DHT is involved in hair biology, but a blood-hormone change does not by itself establish visible hair loss. The 2025 trial improved the evidence by measuring hair density, follicular units, thickness, and hormones together. That design addresses the consumer concern more directly than a hormone ratio alone.
Direct evidence can still have limits. Twelve weeks may not capture slow changes, and 38 completers cannot exclude rare individual responses. The appropriate conclusion is not that every future risk is impossible; it is that the newer controlled study found no group difference in the outcomes it measured.
Personal hair changes can have many causes and should not be diagnosed by stopping or starting a supplement without context. Timing, family history, illness, weight change, medications, and scalp conditions may all matter. A clinician can evaluate the pattern more directly than an online hormone rumor. Photographing the same scalp areas under consistent lighting can also give a clinician better information than memory alone.
Sources & further reading
This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.